At twelve months, the results told a complicated story. Women who attended the in-person classes showed a 10% increase in daily fruit and vegetable intake, while those in the control group saw a 44% decrease. The hands-on, community-centered format appeared to work, at least for diet. The eHealth-only group, however, showed no significant improvement in fruit and vegetable consumption compared to controls. Nor did the combination group — a finding that surprised the research team. "More support does not always mean more effective support," says lead author Dr. Heather Greenlee of Fred Hutchinson Cancer Center. The addition of eHealth to in-person classes did not amplify the benefit, and in this case, might even have negatively affected the benefit seen for those who only attended in person.
The physical activity findings were perhaps the most striking. By twelve months, women in the control group had increased their moderate-to-vigorous physical activity by 53%, while women who received both in-person and eHealth components actually decreased theirs by 34%. The control group– who received only a Fitbit and a single thirty-minute coaching session– outpaced every intervention arm in getting moving.
How do you explain a control group that moved more than the intervention groups? The researchers offer several possibilities. The trial was not blinded, meaning women who knew they hadn't been randomized to a diet or exercise program may have felt motivated to increase their own physical activity. Self-reported physical activity is also notoriously prone to overestimation, and New York City residents may already be more physically active than breast cancer survivors in other regions — limiting how much room there was to improve.
As for the eHealth component, low engagement likely played a role. Only about 55% of participants in those arms responded to even one of the four nutrition goal-setting text messages. And because the study ran from 2016 to 2019, the technology available at the time made it impossible to track whether emails were actually opened and read. Notably, among those who did complete exit interviews, 79% said the text messages and newsletters were somewhat or very helpful– suggesting the content resonated, but reaching people consistently remains a challenge.
The ¡Mi Vida Saludable! trial was notable for its scale, cultural attunement, and design rigor. "The Mi Vida Saludable study was one of the first trials to use a factorial design,” says Dr. Greenlee. Factorial design tests multiple intervention components simultaneously, in this context to study lifestyle change within the chosen population, and it achieved an impressive 93% retention rate over twelve months. But the findings make clear that even well-designed, culturally adapted programs leave room for improvement. "More work needs to be done to identify which supports are needed to help this group of cancer survivors achieve and maintain nutrition and physical activity behaviors," Dr. Greenlee says.
The team is already building on what they learned. An ongoing trial called the VIDA study is now testing an adaptive intervention– using a SMART (Sequential, Multiple Assignment, Randomized Trial) design– an approach that randomizes participants multiple times at key decision points throughout the trial, adjusting the intervention based on how each person is responding, rather than keeping everyone on the same fixed protocol regardless of their progress. The VIDA study is grounded in a culturally adapted version of the Diabetes Prevention Program and delivered via Zoom, including twenty-six classes over a year, hands-on experiential learning, one-on-one health coaching, and take-home toolkits with foods and tools for participants to try.
For the millions of Latina women navigating life after breast cancer, research like this matters, not just for the answers it provides, but for the questions it keeps asking.